Contrast media or contrast agents provide better images of anatomical structures since they increase the image contrast, thus providing better images of body structures and organs. These agents are helpful in providing better visualization of body structures during several medical procedures such as computed tomography (CT), X-ray, catheterization laboratory (cath lab), and ultrasound and magnetic resonance imaging (MRI).
North America accounts for the highest share in global contrast media/ contrast agents market followed by Europe. The reason for North America and Europe being bigger markets is the presence of major players in these regions and the use of contrast agents in most radiological examinations. Among the other regions of the world, Europe is expected to experience a slower growth rate as the country is still struggling with the euro debt crisis of 2011.
Download PDF for Market Insights at http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=876
This market can be segmented in three product categories – iodinated based, barium based, and gadolinium based, which can be further segmented on the basis of their indication, routes of administration, application, and medical procedures.
The factors driving the growth of the market are an increase in the number of chronic diseases such as cancer and the rising demand for image guided surgical procedures. The global reform for better healthcare is also fuelling the growth of the contrast media or contrast agents market. However, sluggish economies of some of the regions like Europe are hindering the growth of this market.
Some of the major players in this industry segment are Bracco Diagnostic, Inc., Covidien, GE Healthcare, Bayer Healthcare Pharmaceuticals, and the Guerbet Group.
This research report analyzes this market depending on its market segments, major geographies, and current market trends.
- Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World